Identification of ADHD risk genes in extended pedigrees by combining linkage analysis and whole-exome sequencing
暂无分享,去创建一个
S. Cichon | L. Kiemeney | B. Franke | K. Lesch | J. Buitelaar | K. Hveem | T. Galesloot | B. Cormand | J. Ramos-Quiroga | M. Ribasés | M. Klein | P. Hoffmann | S. Johansson | M. E. Gabrielsen | J. Haavik | A. Reif | G. Ziegler | G. Poelmans | M. Romanos | C. Jacob | K. Neveling | M. Pauper | J. Corominas | T. Zayats | O. Rivero | Julia M. Geissler | H. Weber | A. Arias Vásquez | Charline Jansch | Evgeniy Svirin | M. Gabrielsen | G. C. Ziegler | Marc Pauper
[1] Erdogan Taskesen,et al. Functional mapping and annotation of genetic associations with FUMA , 2017, Nature Communications.
[2] B. Franke,et al. SLC2A3 single‐nucleotide polymorphism and duplication influence cognitive processing and population‐specific risk for attention‐deficit/hyperactivity disorder , 2017, Journal of child psychology and psychiatry, and allied disciplines.
[3] Daniel P. Newman,et al. Rare DNA variants in the brain-derived neurotrophic factor gene increase risk for attention-deficit hyperactivity disorder: a next-generation sequencing study , 2017, Molecular Psychiatry.
[4] P. Lichtenstein,et al. Familial aggregation of attention‐deficit/hyperactivity disorder , 2017, Journal of child psychology and psychiatry, and allied disciplines.
[5] Aribert Rothenberger,et al. Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism , 2017, Translational Psychiatry.
[6] L. Kiemeney,et al. Cohort Profile Cohort Profile : The Nijmegen Biomedical Study ( NBS ) , 2017 .
[7] S. Cichon,et al. Exome chip analyses in adult attention deficit hyperactivity disorder , 2016, Translational psychiatry.
[8] Kyeong-Man Kim,et al. Functional Regulation of Dopamine D3 Receptor through Interaction with PICK1 , 2016, Biomolecules & therapeutics.
[9] B. Franke,et al. Whole-Exome Sequencing Reveals Increased Burden of Rare Functional and Disruptive Variants in Candidate Risk Genes in Individuals With Persistent Attention-Deficit/Hyperactivity Disorder. , 2016, Journal of the American Academy of Child and Adolescent Psychiatry.
[10] M. Fukunaga,et al. Whole-exome sequencing and neurite outgrowth analysis in autism spectrum disorder , 2015, Journal of Human Genetics.
[11] Joseph T. Glessner,et al. Psychiatric gene discoveries shape evidence on ADHD's biology , 2015, Molecular Psychiatry.
[12] R. Huganir,et al. Role for neonatal D-serine signaling: prevention of physiological and behavioral deficits in adult Pick1 knockout mice , 2015, Molecular Psychiatry.
[13] J. Munson,et al. Whole exome sequencing in extended families with autism spectrum disorder implicates four candidate genes , 2015, Human Genetics.
[14] Edward L. Huttlin,et al. The BioPlex Network: A Systematic Exploration of the Human Interactome , 2015, Cell.
[15] B. Franke,et al. Cognitive impairments are different in single-incidence and multi-incidence ADHD families. , 2015, Journal of child psychology and psychiatry, and allied disciplines.
[16] B. Franke,et al. On the role of NOS1 ex1f‐VNTR in ADHD—allelic, subgroup, and meta‐analysis , 2015, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[17] Joris M. Mooij,et al. MAGMA: Generalized Gene-Set Analysis of GWAS Data , 2015, PLoS Comput. Biol..
[18] K. Lesch,et al. Annual research review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter. , 2015, Journal of child psychology and psychiatry, and allied disciplines.
[19] B. Franke,et al. Simplex and Multiplex Stratification in ASD and ADHD Families: A Promising Approach for Identifying Overlapping and Unique Underpinnings of ASD and ADHD? , 2014, Journal of Autism and Developmental Disorders.
[20] Jan K. Buitelaar,et al. Attention-deficit/hyperactivity disorder , 2015, Nature Reviews Disease Primers.
[21] Eric E Schadt,et al. A role for noncoding variation in schizophrenia. , 2014, Cell reports.
[22] Boris Yamrom,et al. The contribution of de novo coding mutations to autism spectrum disorder , 2014, Nature.
[23] Jana Marie Schwarz,et al. MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.
[24] A. Sjölander,et al. Paternal age at childbearing and offspring psychiatric and academic morbidity. , 2014, JAMA psychiatry.
[25] Eric S. Lander,et al. A polygenic burden of rare disruptive mutations in schizophrenia , 2014, Nature.
[26] B. Franke,et al. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD. , 2013, Journal of the American Academy of Child and Adolescent Psychiatry.
[27] P. Lichtenstein,et al. The heritability of clinically diagnosed attention deficit hyperactivity disorder across the lifespan , 2013, Psychological Medicine.
[28] K. Hveem,et al. COHORT PROFILE Cohort Profile : The HUNT Study , Norway , 2013 .
[29] B. Franke,et al. IMpACTing on adult ADHD research , 2013, European Neuropsychopharmacology.
[30] P. Lichtenstein,et al. Developmental twin study of attention problems: high heritabilities throughout development. , 2013, JAMA psychiatry.
[31] Lars Otten,et al. A system for exact and approximate genetic linkage analysis of SNP data in large pedigrees , 2013, Bioinform..
[32] B. V. van Bon,et al. Diagnostic exome sequencing in persons with severe intellectual disability. , 2012, The New England journal of medicine.
[33] S. Steinberg,et al. Rate of de novo mutations and the importance of father’s age to disease risk , 2012, Nature.
[34] S. Steinberg,et al. Rate of de novo mutations, father’s age, and disease risk , 2012, Nature.
[35] Jing Hu,et al. SIFT web server: predicting effects of amino acid substitutions on proteins , 2012, Nucleic Acids Res..
[36] Li Zou,et al. Role of Dopamine Receptors in ADHD: A Systematic Meta-analysis , 2012, Molecular Neurobiology.
[37] Michael F. Walker,et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism , 2012, Nature.
[38] Evan T. Geller,et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders , 2012, Nature.
[39] Bradley P. Coe,et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations , 2012, Nature.
[40] M. Gill,et al. Investigating the Contribution of Common Genetic Variants to the Risk and Pathogenesis of ADHD , 2012, The American journal of psychiatry.
[41] Susanne Walitza,et al. Genome-Wide Analysis of Copy Number Variants in Attention Deficit Hyperactivity Disorder: The Role of Rare Variants and Duplications at 15q13.3 , 2012, The American journal of psychiatry.
[42] B. Franke,et al. The genetics of attention deficit/hyperactivity disorder in adults, a review , 2011, Molecular Psychiatry.
[43] A. Ploeger,et al. Evolutionary approaches to autism- an overview and integration , 2011, McGill journal of medicine : MJM : an international forum for the advancement of medical sciences by students.
[44] Fassnacht,et al. Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree , 2011, Molecular Psychiatry.
[45] M. Bayés,et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study , 2011, Genes, brain, and behavior.
[46] G. Salmon,et al. Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.
[47] C. Freitag,et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. , 2010, Molecular psychiatry.
[48] H. Stefánsson,et al. Supplementary webappendix , 2018 .
[49] D. Altshuler,et al. A map of human genome variation from population-scale sequencing , 2010, Nature.
[50] G. Willemsen,et al. Genetic Epidemiology of Attention Deficit Hyperactivity Disorder (ADHD Index) in Adults , 2010, PloS one.
[51] P. Bork,et al. A method and server for predicting damaging missense mutations , 2010, Nature Methods.
[52] Stefan Johansson,et al. Multicenter Analysis of the SLC6A3/DAT1 VNTR Haplotype in Persistent ADHD Suggests Differential Involvement of the Gene in Childhood and Persistent ADHD , 2010, Neuropsychopharmacology.
[53] T. Shaikh,et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes , 2010, Molecular Psychiatry.
[54] K. Pollard,et al. Detection of nonneutral substitution rates on mammalian phylogenies. , 2010, Genome research.
[55] I. Waldman,et al. Candidate gene studies of ADHD: a meta-analytic review , 2009, Human Genetics.
[56] B. Franke,et al. Meta‐analysis of genome‐wide linkage scans of attention deficit hyperactivity disorder , 2008, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[57] Susanne Walitza,et al. Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies , 2008, Journal of Neural Transmission.
[58] Rebecca F. Halperin,et al. Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12 , 2008, Molecular Psychiatry.
[59] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[60] G. Torres,et al. The dopamine transporter proteome , 2006, Journal of neurochemistry.
[61] J. Smoller,et al. Molecular Genetics of Attention-Deficit/Hyperactivity Disorder , 2005, Biological Psychiatry.
[62] Joseph Biederman,et al. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies , 2005, Psychological Medicine.
[63] J. Biederman. Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. , 2004, The Journal of clinical psychiatry.
[64] D. Grönemeyer,et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. , 2002, American heart journal.
[65] J. Bockaert,et al. PICK1 is required for the control of synaptic transmission by the metabotropic glutamate receptor 7 , 2002, The EMBO journal.
[66] R. Grantham. Amino Acid Difference Formula to Help Explain Protein Evolution , 1974, Science.